| |
| |
|
| Insider
Information: |
Papa Joseph C |
| Relationship: |
Director |
| City: |
Corona |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
6 |
|
| Direct
Shares |
1,952,222 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$17,560,123 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
1,952,222 |
|
|
| Total
Value |
$17,560,123 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
1
|
0
|
|
Stock
price went up :
|
1
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
1.0
|
0.0
|
| Percentage
Gain/Loss : |
 26.2%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Cardinal Health Inc |
CAH |
Chmn & CEO, Pharm Tech... |
2004-12-13 |
14,400 |
|
0 |
Premium* |
|
|
Perrigo Co |
PRGO |
President and CEO, Cha... |
2013-12-18 |
0 |
2006-10-09 |
0 |
Premium* |
|
|
Bausch Health Companies Inc |
BHC |
Director |
2022-05-10 |
1,427,568 |
2016-05-02 |
0 |
Premium* |
|
|
Prometheus Biosciences, Inc. |
RXDX |
Director |
2023-06-16 |
0 |
2023-06-16 |
0 |
Premium* |
|
|
Bausch & Lomb Corp |
BLCO |
CEO & Chairman, Director |
2022-05-05 |
472,222 |
2022-05-05 |
0 |
Premium* |
|
|
Candel Therapeutics, Inc. |
CADL |
Director |
2022-12-09 |
38,032 |
2022-12-08 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
137 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 6 of 6
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| PRGO |
Perrigo Co |
President and CEOChairman |
• • – |
2013-09-24 |
4 |
AS |
$124.60 |
$1,869,015 |
D/D |
(15,000) |
116,655 |
0 |
- |
|
| PRGO |
Perrigo Co |
President and CEOChairman |
• • – |
2013-09-24 |
4 |
OE |
$35.85 |
$537,750 |
D/D |
15,000 |
131,655 |
0 |
- |
|
| PRGO |
Perrigo Co |
President and CEOChairman |
• • – |
2013-12-09 |
4 |
GD |
$0.00 |
$0 |
D/D |
20,000 |
96,655 |
0 |
- |
|
| PRGO |
Perrigo Co |
President and CEOChairman |
• • – |
2013-12-12 |
4 |
AS |
$149.43 |
$2,251,819 |
D/D |
(15,000) |
116,655 |
0 |
- |
|
| PRGO |
Perrigo Co |
President and CEOChairman |
• • – |
2013-12-12 |
4 |
OE |
$30.06 |
$728,401 |
D/D |
15,000 |
125,506 |
0 |
- |
|
| PRGO |
Perrigo Co |
President and CEOChairman |
• • – |
2013-12-18 |
4 |
D |
$0.00 |
$0 |
D/D |
(96,655) |
0 |
0 |
- |
|
| RXDX |
Prometheus Biosciences, I... |
Director |
– • – |
2021-03-16 |
4 |
B |
$19.00 |
$285,000 |
D/D |
15,000 |
15,000 |
2.39 |
% |
|
| RXDX |
Prometheus Biosciences, I... |
Director |
– • – |
2023-05-19 |
4 |
A |
$0.00 |
$0 |
D/D |
2,278 |
17,278 |
0 |
- |
|
| RXDX |
Prometheus Biosciences, I... |
Director |
– • – |
2023-06-02 |
4 |
A |
$0.00 |
$0 |
I/I |
10,000 |
10,000 |
0 |
- |
|
| RXDX |
Prometheus Biosciences, I... |
Director |
– • – |
2023-06-02 |
4 |
D |
$0.00 |
$0 |
D/D |
(10,000) |
7,278 |
0 |
- |
|
| RXDX |
Prometheus Biosciences, I... |
Director |
– • – |
2023-06-16 |
4 |
D |
$0.00 |
$0 |
I/I |
(10,000) |
0 |
0 |
- |
|
| RXDX |
Prometheus Biosciences, I... |
Director |
– • – |
2023-06-16 |
4 |
D |
$0.00 |
$0 |
D/D |
(7,278) |
0 |
0 |
- |
|
137 Records found
|
|
Page 6 of 6 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
